Peter A. Thompson

Insider Reports History

Location
Hayward, CA
Signature
/s/ Peter A. Thompson
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Peter A. Thompson:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Sionna Therapeutics, Inc. Director Common Stock 3.6M $160M $44.49 19 Dec 2025 Indirect
Corvus Pharmaceuticals, Inc. Director, 10%+ Owner Common Stock 7.17M $29.8M $4.16 27 Jun 2025 Indirect
Edgewise Therapeutics, Inc. Director, 10%+ Owner Common Stock 444K $8.93M $20.13 03 Apr 2025 Indirect
ALPINE IMMUNE SCIENCES, INC. Director Common Stock 0 $0 $6.33 18 May 2024 Indirect
ARS Pharmaceuticals, Inc. Director Common Stock 0 $0 $13.00 26 Aug 2024 Indirect
ARS Pharmaceuticals, Inc. Director Stock Option (right to buy) 30K 25 Jun 2025 Direct
Edgewise Therapeutics, Inc. Director, 10%+ Owner Stock Option (Right to Buy) 30K 16 Jun 2025 Direct
Sionna Therapeutics, Inc. Director Non-Qualified Stock Option (right to buy) 20K 12 Jun 2025 Direct
PMV Pharmaceuticals, Inc. Director, 10%+ Owner Stock option (right to buy) 16.3K 02 Jun 2022 Direct
Corvus Pharmaceuticals, Inc. Director, 10%+ Owner Stock Option (Right to Buy) 15K 12 Jun 2025 Direct
Janux Therapeutics, Inc. Director Stock Option (right to buy) 12.5K 14 Jun 2022 Direct
Decibel Therapeutics, Inc. Director, 10%+ Owner Stock Option (right to buy) 10K 17 Jun 2022 Direct
ALPINE IMMUNE SCIENCES, INC. Director Stock Option (Right to buy) 0 20 May 2024 Direct
ALPINE IMMUNE SCIENCES, INC. Director Warrant (Right to Buy) 0 11 Jan 2024 Indirect
Corvus Pharmaceuticals, Inc. Director, 10%+ Owner Common Warrants (right to buy) 0 27 Jun 2025 Indirect
Sionna Therapeutics, Inc. Director Series B convertible preferred stock 0 10 Feb 2025 By OrbiMed Private Investments VIII, LP
Sionna Therapeutics, Inc. Director Series C convertible preferred stock 0 10 Feb 2025 By OrbiMed Private Investments VIII, LP

Insider Reports Filed by Peter A. Thompson

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SION Sionna Therapeutics, Inc. 17 Dec 2025 3 -$83.4K 4 Director 19 Dec 2025, 19:24
SION Sionna Therapeutics, Inc. 24 Nov 2025 3 -$4.81M 4 Director 26 Nov 2025, 18:41
CRVS Corvus Pharmaceuticals, Inc. 27 Jun 2025 3 $0 4 Director, 10%+ Owner 01 Jul 2025, 21:17
SPRY ARS Pharmaceuticals, Inc. 25 Jun 2025 1 $0 4 Director 27 Jun 2025, 16:30
EWTX Edgewise Therapeutics, Inc. 16 Jun 2025 1 $0 4 Director, 10%+ Owner 18 Jun 2025, 19:36
SION Sionna Therapeutics, Inc. 12 Jun 2025 1 $0 4 Director 16 Jun 2025, 17:08
CRVS Corvus Pharmaceuticals, Inc. 12 Jun 2025 1 $0 4 Director, 10%+ Owner 16 Jun 2025, 16:26
EWTX Edgewise Therapeutics, Inc. 03 Apr 2025 2 $10M 4 Director, 10%+ Owner 04 Apr 2025, 19:42
SION Sionna Therapeutics, Inc. 10 Feb 2025 4 $9.9M 4 Director 10 Feb 2025, 16:05
SION Sionna Therapeutics, Inc. 06 Feb 2025 0 $0 3 Director 06 Feb 2025, 21:06
SPRY ARS Pharmaceuticals, Inc. 26 Aug 2024 1 -$1.09M 4 Director 28 Aug 2024, 16:30
SPRY ARS Pharmaceuticals, Inc. 21 Aug 2024 4 -$11.5M 4 Director 23 Aug 2024, 18:41
SPRY ARS Pharmaceuticals, Inc. 20 Jun 2024 1 $0 4 Director 24 Jun 2024, 17:00
CRVS Corvus Pharmaceuticals, Inc. 13 Jun 2024 1 $0 4 Director, 10%+ Owner 17 Jun 2024, 16:41
EWTX Edgewise Therapeutics, Inc. 10 Jun 2024 1 $0 4 Director, 10%+ Owner 12 Jun 2024, 19:33
ALPN ALPINE IMMUNE SCIENCES, INC. 18 May 2024 9 $0 4 Director 20 May 2024, 20:09
CRVS Corvus Pharmaceuticals, Inc. 06 May 2024 2 $2.5M 4 Director, 10%+ Owner 08 May 2024, 20:34
EWTX Edgewise Therapeutics, Inc. 23 Jan 2024 1 $5M 4 Director, 10%+ Owner 25 Jan 2024, 16:32
ALPN ALPINE IMMUNE SCIENCES, INC. 11 Jan 2024 2 $1.85M 4 Director 16 Jan 2024, 16:36
ALPN ALPINE IMMUNE SCIENCES, INC. 02 Jan 2024 1 $0 4 Director 04 Jan 2024, 19:02
ALPN ALPINE IMMUNE SCIENCES, INC. 27 Dec 2023 6 -$28.7M 4 Director 29 Dec 2023, 16:20
CRVS Corvus Pharmaceuticals, Inc. 06 Dec 2023 1 $0 4 Director, 10%+ Owner 08 Dec 2023, 16:02
SPRY ARS Pharmaceuticals, Inc. 29 Aug 2023 1 $3.1M 4 Director 31 Aug 2023, 17:18
SPRY ARS Pharmaceuticals, Inc. 27 Jun 2023 1 $0 4 Director, 10%+ Owner 28 Jun 2023, 21:00
CRVS Corvus Pharmaceuticals, Inc. 15 Jun 2023 1 $0 4 Director, 10%+ Owner 20 Jun 2023, 17:03
EWTX Edgewise Therapeutics, Inc. 12 Jun 2023 1 $0 4 Director, 10%+ Owner 14 Jun 2023, 19:29
ALPN ALPINE IMMUNE SCIENCES, INC. 03 Jan 2023 1 $0 4 Director 05 Jan 2023, 18:07
EWTX Edgewise Therapeutics, Inc. 16 Sep 2022 1 $5M 4 Director, 10%+ Owner 16 Sep 2022, 16:34
CRVS Corvus Pharmaceuticals, Inc. 11 Aug 2022 1 $0 4 Director, 10%+ Owner 15 Aug 2022, 18:47
EWTX Edgewise Therapeutics, Inc. 24 Jun 2022 1 $0 4 Director, 10%+ Owner 28 Jun 2022, 19:17
DBTX Decibel Therapeutics, Inc. 17 Jun 2022 1 $0 4 Director, 10%+ Owner 21 Jun 2022, 18:54
CRVS Corvus Pharmaceuticals, Inc. 15 Jun 2022 1 $0 4 Director, 10%+ Owner 17 Jun 2022, 17:35
JANX Janux Therapeutics, Inc. 14 Jun 2022 1 $0 4 Director 16 Jun 2022, 16:35
SPRY Silverback Therapeutics, Inc. 10 Jun 2022 1 $0 4 Director, 10%+ Owner 13 Jun 2022, 19:52
EWTX Edgewise Therapeutics, Inc. 18 May 2022 1 $995K 4 Director, 10%+ Owner 20 May 2022, 16:32
ALPN ALPINE IMMUNE SCIENCES, INC. 03 Jan 2022 1 $0 4 Director, 10%+ Owner 04 Jan 2022, 16:19
JANX Janux Therapeutics, Inc. 29 Dec 2021 2 -$820K 4 Director 30 Dec 2021, 19:55
JANX Janux Therapeutics, Inc. 21 Dec 2021 2 -$2.27M 4 Director 23 Dec 2021, 15:08
JANX Janux Therapeutics, Inc. 16 Dec 2021 2 -$7.5M 4 Director 17 Dec 2021, 16:16
CRVS Corvus Pharmaceuticals, Inc. 20 Sep 2021 1 -$6.76M 4 Director, 10%+ Owner 22 Sep 2021, 17:24
ALPN ALPINE IMMUNE SCIENCES, INC. 17 Sep 2021 2 $9.5M 4 Director, 10%+ Owner 21 Sep 2021, 18:38
CRVS Corvus Pharmaceuticals, Inc. 09 Sep 2021 1 $0 4 Director, 10%+ Owner 13 Sep 2021, 16:53
JANX Janux Therapeutics, Inc. 15 Jun 2021 8 $12M 4 Director 16 Jun 2021, 18:20
CRVS Corvus Pharmaceuticals, Inc. 15 Jun 2021 1 $0 4 Director, 10%+ Owner 16 Jun 2021, 16:15
JANX Janux Therapeutics, Inc. 10 Jun 2021 1 $0 4 Director, 10%+ Owner 14 Jun 2021, 17:43
JANX Janux Therapeutics, Inc. 10 Jun 2021 0 $0 3 Director 10 Jun 2021, 19:22
SPRY Silverback Therapeutics, Inc. 04 Jun 2021 1 $0 4 Director, 10%+ Owner 21 Sep 2021, 17:14
PMVP PMV Pharmaceuticals, Inc. 02 Jun 2021 1 $0 4 Director, 10%+ Owner 09 Jun 2021, 17:41